Clinical Trial Update: Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating rhBMP-2 with a calcium phosphate carrier for closed distal radius fractures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Radius Fracture

Drugs mentioned

• rhBMP-2/CPM (recombinant human bone morphogenetic protein-2 with calcium phosphate matrix)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Radius Fractures | Phase 1 | Status: COMPLETED